Roche Signs an AI-Based Research Agreement with Sensyne Health
Shots:
- Roche and Sensyne Health collaborate to apply AI technology for clinical trial designs and will further strengthen Roche’s approach in data and technology-driven personalized healthcare
- The collaboration will focus on identifying patient’s population in one disease and further assessing and collating anonymized patient data with anonymized EHR data for supporting clinical trial planning
- In 2019- Sensyne collaborated with Bayer to accelerate the clinical development of new treatments for cardiovascular disorders
Click here to read full press release/ article
Ref: Sensyne Health | Image: Roche
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com